antisense oligonucleotide targeted to human transthyretin (TTR) mRNA

antisense oligonucleotide targeted to human transthyretin (TTR) mRNA
Trade Name
Orphan Indication Hereditary ATTR amyloidosis
USA Market Approval USA
USA Designation Date 2012-07-24 00:00:00
Sponsor Ionis Pharmaceuticals, Inc.;2855 Gazelle Court;Carlsbad, California, 92010